Table 3.

Comparison of celiac antibodies according to comorbidities within the psoriasis group.

	Hypertension		p	Type 2 diabetes		p
	Present a n = 14	Absent b n = 39		Present c n = 15	Absent b n = 39
Antigliadin IgA, median (IQR:25–75)	4.2 (2.3–8.8)	2.3 (1.5–4.1)	0.005*	3.1 (2.0–4.3)	2.1 (1.1–3.9)	0.49
Antigliadin IgG, median (IQR:25–75)	3.6 (3.0–5.9)	3.2 (2.1–5.2)	0.62	3.2 (2.2–5.3)	2.8 (2.1–6.6)	0.20
Anti-TTG IgA, median (IQR:25–75)	1.9 (1.0–4.8)	2.4 (1.2–4.3)	0.55	2.4 (1.2–4.5)	2.1 (0.4–3.3)	0.82
Anti-TTG IgG, median (IQR:25–75)	2.5 (0.8–4.4)	2.2 (1.1–4.5)	0.58	2.5 (1.0–4.5)	2.1 (1.2–5.1)	0.79

IQR; interquartile range, TTG; tissue transglutaminase.

^aIn this group, five patients with hypertension had type 2 diabetes mellitus and two patients had chronic obstructive pulmonary disease.

^bThis group includes patients with psoriasis and no other comorbidities.

^cFive patients in this group had hypertension accompanying type 2 diabetes.